高级检索

新型5-氨基-2-(苄基硫代)噻唑-4-甲酰胺类化合物的设计、合成及抗肿瘤活性

Design, synthesis and anti-tumor activity of novel 5-amino-2-(benzylthio)thiazole-4-carboxamide derivatives

  • 摘要: 为了寻找具有更好抗肿瘤活性的化合物,设计合成了一系列5-氨基-2-(苄基硫代)噻唑-4-甲酰胺衍生物。以2-氨基-2-氰基-乙酰胺为起始原料,合成了16个化合物 DDO-5401 ~ DDO-5416 ;目标化合物结构经IR、1H NMR和ESI-MS确证;采用MTT法对目标化合物进行5株肿瘤细胞(HCT116、HepG2、A549、MDA-MB-231、MCF-7)体外抗肿瘤活性测定。合成的化合物对肿瘤细胞尤其是A549细胞表现出了良好的抑制活性;构效关系研究表明,苯环上连有给电子基团的化合物抑制活性要好于连有吸电子基团的化合物。化合物 DDO-5413 的抑制活性最强,对乳腺癌细胞MDA-MB-231和MCF-7抑制活性好于阳性对照药达沙替尼,值得进一步研究。

     

    Abstract: A series of 5-amino-2-(benzylthio)thiazole-4-carboxamide derivatives were designed and synthesized to discover novel compounds with anti-tumor activity. Compounds DDO-5401 - DDO-5416 were synthesized using 2-amino-2-cyanoacetamide as the start material. The structures of the synthesized compounds were confirmed by IR, 1H NMR and ESI-MS. The in vitro anti-tumor activities of the synthesized compounds were determined by MTT assay in HCT116, HepG2, A549, MDA-MB-231 and MCF-7 cell lines. Target compounds showed good anti-tumor activity especially in A549 cell line. SAR study showed that electron donating groups were more favorable than electron absorption ones. Compound DDO-5413 exhibited noteworthy activity in MDA-MB-231 and MCF-7 cell lines with IC50 value lower than the positive reference dasatinib. It suggested that DDO-5413 might be the candidate for further investigation.

     

/

返回文章
返回